Group 506

Regulation and Immune Homeostasis in Pathologies Related to the Immune System

Director
Rafael Correa Rocha, Marjorie Pion
Group type
CONSOLIDATED
Research lines

Axis 1: New diagnostic and therapeutic techniques

L1: Development of extracellular vesicles produced in the culture of thymus regulatory T cells.

Axis 2: Precision medicine

L1: Development of genetically modified regulatory T cells for antigen specificity

L2: Cell therapy with thyTreg cells in children with heart transplants

L3: Immune regulation and immune disorders in paediatric diseases

L4: Role of Treg cells in paediatric patients with Immunodeficiencies

Axis 3: Infectious diseases

L1: Study of the immune system of patients infected by SARS-CoV-2 or vaccinated by mRNA-based vaccines

Axis 4: New diagnostic and therapeutic techniques

L1: Allogeneic use of thyTreg in inflammatory diseases

Research group members:

Rafael Correa Rocha: Group leader (PI)

Marjorie Pion: Group leader (PI)

María Elena Seoane Reula: Clinical researcher (specialist in Immunology and Allergology)

Diana Carolina Hernández Flórez: Postdoctoral researcher - Clinical Trials Coordinator

Vanessa Beltrán Pretell: Senior graduate - Clinical Trials Coordinator

Ivana Zagorac: Senior postdoctoral researcher

Sandra Gómez Arconada: Predoctoral researcher

Sara Benavente García: Predoctoral researcher

Rocío López Esteban: Laboratory technician

Raquel Sáez Raspeño: Laboratory technician

Sergio Checa Fernández: Laboratory technician

Aitana de la Cruz Tabernero: Laboratory technician

Jesús Rosales Magallares: Predoctoral researcher

Laura Merino Fernández: Predoctoral researcher